WRN counteracts the NHEJ pathway upon camptothecin exposure

Biochemical and Biophysical Research Communications

Volumn 355, Issue 2, 2007, Pages 477-482

  Otsuki, Makoto ^a   Seki, Masayuki ^a   Kawabe, Yoh ichi ^a   Inoue, Eri ^a   Dong, Yu Peng ^a   Abe, Takuya ^a   Kato, Genta ^a   Yoshimura, Akari ^a   Tada, Shusuke ^a   Enomoto, Takemi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

BLM; CPT; DNA PKcs; DT40; Etoposide; Ku70; PARP 1; RecQ; TopI; WRN

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; CAMPTOTHECIN; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; KU ANTIGEN; WERNER SYNDROME PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA REPAIR; DRUG ACTIVITY; DRUG SENSITIVITY; GENE DELETION; GENE DISRUPTION; KNOCKOUT GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; WERNER SYNDROME; WILD TYPE;

ANTIGENS, NUCLEAR; BLOTTING, SOUTHERN; CAMPTOTHECIN; CELL LINE; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; HUMANS; RECOMBINATION, GENETIC; RECQ HELICASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

DAMALISCUS LUNATUS;

EID: 33847158810     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.175     Document Type: Article

References (17)

1. Epstein C.J., Martin G.M., Schultz A.L., and Motulsky A.G. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 45 (1966) 177-221
2. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alisch R., Matthews S., Nakura J., Miki T., Martin G.M., Mulligan J., and Schellenberg G.D. Positional cloning of the Werner's syndrome gene. Science 272 (1996) 258-262
3. Suzuki N., Shimamoto A., Imamura O., Kuromitsu J., Kitao S., Goto M., and Furuichi Y. DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res. 25 (1997) 2973-2978
4. Gray M.D., Shen J.C., Kamath-Loeb A.S., Blank A., Sopher B.L., Martin G.M., Oshima J., and Loeb L.A. The Werner syndrome protein is a DNA helicase. Nat. Genet. 17 (1997) 100-103
5. Huang S., Li B., Gray M.D., Oshima J., Mian I.S., and Campisi J. The premature ageing syndrome protein, WRN, is a 3′ -->5′ exonuclease. Nat. Genet. 20 (1998) 114-116
6. Suzuki N., Shiratori M., Goto M., and Furuichi Y. Werner syndrome helicase contains a 5′ -->3′ exonuclease activity that digests DNA and RNA strands in DNA/DNA and RNA/DNA duplexes dependent on unwinding. Nucleic Acids Res. 27 (1999) 2361-2368
7. Bachrati C.Z., and Hickson I.D. RecQ helicases: suppressors of tumorigenesis and premature aging. Biochem. J. 374 (2003) 577-606
8. Bohr V.A. Deficient DNA repair in the human progeroid disorder, Werner syndrome. Mutat. Res. 577 (2005) 252-259
9. Cooper M.P., Machwe A., Orren D.K., Brosh R.M., Ramsden D., and Bohr V.A. Ku complex interacts with and stimulates the Werner protein. Genes. Dev. 14 (2000) 907-912
10. Li B., and Comai L. Functional interaction between Ku and the Werner syndrome protein in DNA end processing. J. Biol. Chem. 275 (2000) 28349-28352
11. von Kobbe C., Harrigan J.A., Schreiber V., Stiegler P., Piotrowski J., Dawut L., and Bohr V.A. Poly(ADP-ribose) polymerase 1 regulates both the exonuclease and helicase activities of the Werner syndrome protein. Nucleic Acids Res. 32 (2004) 4003-4014
12. Li B., Navarro S., Kasahara N., and Comai L. Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly(ADP-ribose) polymerase-1. J. Biol. Chem. 279 (2004) 13659-13667
13. Hochegger H., Dejsuphong D., Fukushima T., Morrison C., Sonoda E., Schreiber V., Zhao G.Y., Saberi A., Masutani M., Adachi N., Koyama H., de Murcia G., and Takeda S. Parp-1 protects homologous recombination from interference by Ku and Ligase IV in vertebrate cells. EMBO J. 25 (2006) 1305-1314
14. Imamura O., Fujita K., Itoh C., Takeda S., Furuichi Y., and Matsumoto T. Werner and Bloom helicases are involved in DNA repair in a complementary fashion. Oncogene 21 (2002) 954-963
15. Adachi N., Suzuki H., Iiizumi S., and Koyama H. Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage. J. Biol. Chem. 278 (2003) 35897-358902
16. Adachi N., So S., and Koyama H. Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage. J. Biol. Chem. 279 (2004) 37343-37348
17. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6 (2006) 789-802